We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$43.8B
AUM Growth
+$2.95B
(+7.2%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
29.71%
Holding
2,321
New
255
Increased
1,689
Reduced
325
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$408M |
| 2 |
NVIDIA
NVDA
|
+$395M |
| 3 |
Microsoft
MSFT
|
+$382M |
| 4 |
Amazon
AMZN
|
+$253M |
| 5 |
Palantir
PLTR
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$285M |
| 2 |
NextEra Energy
NEE
|
+$207M |
| 3 |
West Pharmaceutical
WST
|
+$168M |
| 4 |
Broadcom
AVGO
|
+$133M |
| 5 |
Meta Platforms (Facebook)
META
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.42% |
| 2 | Consumer Discretionary | 10.78% |
| 3 | Consumer Staples | 10.15% |
| 4 | Industrials | 10.05% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
CG Oncology
CGON
$6.11B
| $475K | ﹤0.01% |
16,561
+7,599
| +85% | +$260K |
|
1302
MillerKnoll
MLKN
$1.5B
| $475K | ﹤0.01% |
21,012
+6,457
| +44% | +$156K |
|
1303
MaxLinear
MXL
$6.49B
| $475K | ﹤0.01% |
23,996
+7,409
| +45% | +$119K |
|
1304
Penumbra
PEN
$12.5B
| $474K | ﹤0.01% |
1,998
-56
| -3% | -$12.7K |
|
1305
World Kinect Corp
WKC
$1.96B
| $474K | ﹤0.01% |
17,225
-7,053
| -29% | -$202K |
|
1306
VSE Corp
VSEC
$5.48B
| $472K | ﹤0.01% |
4,958
-1,044
| -17% | -$110K |
|
1307
Amneal Pharmaceuticals
AMRX
$5.72B
| $471K | ﹤0.01% |
59,493
+29,424
| +98% | +$247K |
|
1308
Upbound Group
UPBD
$1.19B
| $469K | ﹤0.01% |
16,071
-6,121
| -28% | -$190K |
|
|
HUT
1309
Hut 8
HUT
$12.4B
| $467K | ﹤0.01% |
22,801
+7,492
| +49% | +$153K |
|
|
LTC
1310
LTC Properties
LTC
$2.16B
| $466K | ﹤0.01% |
13,487
+4,515
| +50% | +$167K |
|
1311
Tennant Co
TNC
$1.5B
| $466K | ﹤0.01% |
5,712
+1,758
| +44% | +$155K |
|
1312
IES Holdings
IESC
$12.5B
| $466K | ﹤0.01% |
2,317
+762
| +49% | +$183K |
|
1313
Woodward
WWD
$25B
| $464K | ﹤0.01% |
2,790
-2,412
| -46% | -$412K |
|
1314
SiriusPoint
SPNT
$2.98B
| $464K | ﹤0.01% |
28,300
+7,750
| +38% | +$112K |
|
1315
Ally Financial
ALLY
$13.1B
| $462K | ﹤0.01% |
12,833
+882
| +7% | +$32K |
|
1316
Integra LifeSciences
IART
$1.54B
| $462K | ﹤0.01% |
20,361
+6,266
| +44% | +$137K |
|
|
REVG
1317
DELISTED
REV Group
REVG
| $461K | ﹤0.01% |
14,462
+4,759
| +49% | +$141K |
|
|
SGI
1318
Somnigroup International
SGI
$15.1B
| $461K | ﹤0.01% |
8,125
+556
| +7% | +$29.7K |
|
1319
PagerDuty
PD
$700M
| $460K | ﹤0.01% |
25,219
+7,835
| +45% | +$150K |
|
1320
Aramark
ARMK
$15B
| $460K | ﹤0.01% |
12,325
+841
| +7% | +$32.7K |
|
1321
Celldex Therapeutics
CLDX
$2.77B
| $460K | ﹤0.01% |
18,192
+5,986
| +49% | +$163K |
|
1322
Churchill Downs
CHDN
$6.03B
| $459K | ﹤0.01% |
3,439
+238
| +7% | +$33K |
|
1323
Core & Main
CNM
$8.17B
| $459K | ﹤0.01% |
9,017
+607
| +7% | +$28.6K |
|
1324
Adeia
ADEA
$2.86B
| $459K | ﹤0.01% |
32,799
+10,096
| +44% | +$128K |
|
1325
Surgery Partners
SGRY
$2.06B
| $458K | ﹤0.01% |
21,629
+7,116
| +49% | +$187K |
|
Similar funds
ProShare Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, ProShare Advisors held 2,321 positions worth $43.8B, up 7.2% from $40.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
ProShare Advisors deployed $2.92B of net new capital in Q4 2024, opening 255 new positions and adding to 1,689 existing holdings. Its largest new stake was Applovin: 338,942 shares worth $110M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Walmart Inc, an estimated $285M trimmed.
- ProShare Advisors's largest Q4 2024 buy was Applovin: 338,942 shares worth $110M.
- ProShare Advisors added most to Apple in Q4 2024, an estimated $408M increase.
- ProShare Advisors's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $285M.
- ProShare Advisors fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $3.25M.
- ProShare Advisors's ten largest holdings make up 30% of its $43.8B portfolio in Q4 2024.
- ProShare Advisors opened 255 new positions and closed 50 in Q4 2024.
- ProShare Advisors's portfolio value rose 7.2% quarter-over-quarter to $43.8B.
Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.